25. June 2018

The blending of powders is a critical step in pharmaceutical drug product manufacturing as it ensures that each dosage unit will contain the same intended fraction of active pharmaceutical ingredient (API). Under-blending thus poses a significant risk to patients where overdose or underdose can occur. Similarly, over-blending can lead to manufacturing issues such as reduced tablet tensile strengths as any included lubricants are dispersed further and further with additional blending. For these...